“Design and Rationale of the OPTIMA Study: Retreatment or Step-Up Therapy with Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU)” (2018) SKIN The Journal of Cutaneous Medicine, 2(S1), p. S51. doi:10.25251/skin.2.supp.51.